De Barsy syndrome is a rare genetic condition that affects skin, growth, and development. Many people first hear about De Barsy syndrome when a baby has very loose skin and feeding or muscle tone problems. Features often include soft, sagging skin, small size, eye problems like clouded corneas, and developmental delays, and these are usually noticed in infancy and continue lifelong. Care focuses on supportive therapies such as nutrition support, physical and occupational therapy, vision care, and seizure management if needed. The outlook varies by severity, and specialized care teams can help many children with De Barsy syndrome achieve the best possible quality of life.
Overview
De barsy syndromeSymptoms
People with De Barsy syndrome often have loose, inelastic skin and an aged look at birth. Other features can include developmental delay, low muscle tone, joint laxity, feeding difficulties, poor growth, and eye problems like cloudy corneas or cataracts.
Outlook and prognosis
Most people with De Barsy syndrome have lifelong challenges with growth, movement, vision, and learning, and often need support from multiple specialists. Early, steady therapies can improve comfort, mobility, and communication. Life expectancy varies and depends on complications, especially infections and feeding difficulties.
Causes and risk factors
De Barsy syndrome results from changes in PYCR1 or ALDH18A1, usually inherited autosomal recessively. Risk rises when both parents are carriers, especially in consanguineous families; de novo variants occur. It begins before birth; environmental or lifestyle factors aren’t known drivers.
Genetic influences
Genetics are central in De Barsy syndrome. Most cases result from inherited changes in genes that affect elastic tissue and development, typically passed in an autosomal recessive pattern. Genetic testing confirms the diagnosis and guides family planning and recurrence risk.
Diagnosis
Doctors suspect De Barsy syndrome from features like loose skin, distinctive facial features, eye movement problems, and developmental delay. Confirmation uses genetic tests for ALDH18A1 or PYCR1, supported by imaging and exams; genetic diagnosis of De Barsy syndrome guides care.
Treatment and drugs
Treatment for De Barsy syndrome focuses on comfort, development, and preventing complications. Care often includes seizure control, eye care for corneal problems, tailored nutrition and feeding support, physical and occupational therapy, and proactive treatment of infections and breathing issues. A coordinated team—neurology, ophthalmology, genetics, nutrition, and rehabilitation—adjusts plans as needs change.
Symptoms
In De barsy syndrome, everyday challenges often involve feeding, movement, and vision. Early on, this might look like poor weight gain, very loose skin, or a baby who feels extra floppy when held. The early features of De barsy syndrome usually appear in infancy and can range from subtle to very noticeable. What shows up can vary widely, and some needs change as a child grows.
Skin may hang in folds and feel less springy. Clinicians call this cutis laxa, which means the skin doesn’t bounce back as it usually would. This is a hallmark in De barsy syndrome.
Facial features may look older than expected for age, with fine wrinkles and less fat under the skin. This “progeroid” look can be noticeable in photos. It doesn’t reflect the child’s overall health on its own.
Babies may tire during feeds, cough with swallowing, or have reflux. This can make it hard to take in enough calories. Mealtimes can take longer and require extra pacing.
Height and weight can fall below expected ranges over time. Doctors may describe this as failure to thrive, meaning slower-than-typical growth. In De barsy syndrome, growth often remains below peers even with good nutrition.
How people usually first notice De barsy syndrome?
Families often first notice De Barsy syndrome in the newborn period or early infancy, when a baby has unusually loose, wrinkled skin that looks thin and inelastic, along with a small face and prominent eyes. Doctors may pick up additional early features such as poor weight gain, low muscle tone, feeding difficulties, and eye problems like clouding of the cornea, which together raise concern for a connective tissue–related condition. These first signs of De Barsy syndrome often lead to referral to genetics and ophthalmology to confirm the diagnosis and guide early care.
Types of De barsy syndrome
De Barsy syndrome is a rare genetic condition. Clinically, there appear to be a few recognizable variants that differ in skin looseness, joint laxity, and the degree of developmental and neurologic involvement. Clinicians often describe them in these categories:
Classical phenotype
Marked loose, inelastic skin with visible veins and very flexible joints. Developmental delay and movement differences are common, with feeding challenges in infancy. Vision issues such as clouded lenses can appear early.
Skin‑predominant variant
Skin laxity and early wrinkling stand out, while neurologic features are milder. Growth and development may be closer to peers, though hypotonia can still be present. Eye findings may be limited or appear later.
Neurologic‑predominant variant
Muscle tone, coordination, and developmental delays are more prominent than skin features. Seizures or movement patterns can occur in some. Skin laxity is present but less striking day to day.
Ocular‑dominant variant
Eye problems like early cataracts and corneal clouding are the first signs noticed. Skin and joint laxity are present but may be subtler. Early eye care can help protect vision.
ATP6V0A2‑related form
Changes in the ATP6V0A2 gene underlie this form, known medically as an ATPase‑related cutis laxa. Features often include loose skin, developmental delay, and eye involvement. Not everyone will experience every type of symptom.
PYCR1‑related form
Variants of the PYCR1 gene can produce a De Barsy–like picture with prominent skin laxity. Neurologic features vary from mild to more pronounced. This highlights that types of De Barsy syndrome can look different between families.
What genetics can tell you about symptoms
Some genetic changes in the ALDH18A1 or PYCR1 genes disrupt how cells make proline, a building-block that helps skin, eyes, and connective tissue stay resilient. This can lead to loose, wrinkled skin, joint laxity, poor growth, eye problems, movement issues, and developmental delays.
Causes and risk factors
De Barsy syndrome is caused by gene changes that affect how connective tissue forms. Most known cases involve PYCR1 or ALDH18A1, and the changes are usually inherited from both parents. Some risks are written in our DNA, passed down through families. Risk is higher with a family history or when parents are related, and new mutations can occur. Environment and lifestyle do not cause it, but nutrition, infections, or sun exposure may shape how early symptoms of De Barsy syndrome appear.
Environmental and biological risk factors
De Barsy syndrome is a rare condition present from birth. There are currently no well-established environmental or body-based risks known to increase its likelihood. Researchers are still exploring how outside influences interact with our inner biology. Early symptoms of De Barsy syndrome may prompt evaluation, but they do not change the risk because the condition begins during fetal development.
No well-defined environmental or body-based risks have been identified for De Barsy syndrome. Published reports do not show a consistent pattern that increases likelihood.
Research has not found a clear link between advanced maternal or paternal age and De Barsy syndrome. Reported cases occur across a broad range of parent ages.
Specific toxins, infections, or medications have not been shown to raise the chance of De Barsy syndrome. Standard pregnancy precautions remain important for general fetal health.
Common maternal conditions like high blood pressure or diabetes have not been tied to a higher likelihood of De Barsy syndrome. Good prenatal care still supports the best overall outcomes.
Genetic risk factors
In De Barsy syndrome, the root cause is usually a change in one of two genes that help the body make proline and support healthy connective tissue. Some risk factors are inherited through our genes. Many families carry these changes without symptoms; a child is affected only when two nonworking copies come together. Understanding the genes can also explain why early symptoms of De Barsy syndrome often appear in the first months of life.
PYCR1 gene changes: PYCR1 helps cells handle stress and make proline, which supports skin and connective tissue. Harmful changes in both copies are a common genetic cause of De Barsy syndrome. They can lead to loose skin, growth concerns, and early eye findings.
ALDH18A1 gene changes: This gene is needed to produce proline and related molecules used throughout the body. Variants that stop it from working in both copies can also cause De Barsy syndrome. The clinical picture often overlaps with PYCR1-related cases.
Autosomal recessive pattern: A child must inherit two altered copies of the same De Barsy–related gene, one from each parent. Parents are typically healthy carriers with one working and one altered copy. Each pregnancy has a 25% (1 in 4) chance of an affected child.
Sibling risk: If one child is affected, future pregnancies in the same parents carry a 25% (1 in 4) chance of De Barsy syndrome. Unaffected siblings have a 50% chance to be carriers. Carrier testing in relatives can clarify who carries the family change.
Parental relatedness: When parents are related by blood, they are more likely to share the same rare gene change. This increases the chance a child inherits two altered copies. The condition remains uncommon overall.
Lifestyle risk factors
De barsy syndrome is not caused by lifestyle choices, but daily habits can influence comfort, function, and complications over time. Understanding how lifestyle affects De barsy syndrome can guide families toward routines that support skin, joints, vision, growth, and breathing. The aim is to reduce preventable strain and help therapies work better. Work with your care team to tailor these habits to individual needs.
High-calorie, protein-rich meals can help counter poor weight gain and low muscle tone. Regular, small feedings support energy needs for therapy and development.
Upright positioning and slow-paced feeds may lower reflux and aspiration risk linked to weak muscle tone. Thickened liquids or specialized nipples can make swallowing safer.
Daily, low-impact movement helps maintain muscle strength and motor skills without stressing lax joints. Consistency is more important than intensity to avoid fatigue and injury.
Avoid overstretching and high-impact activities that can worsen joint laxity or cause dislocations. Bracing and supportive footwear, as advised, can stabilize alignment during play and therapy.
Risk prevention
De Barsy syndrome is a genetic condition present from birth, so we can’t prevent the condition itself, but we can lower the chance of complications and support day‑to‑day health. Prevention can mean both medical steps, like vaccines, and lifestyle steps, like exercise. Knowing the early symptoms of De Barsy syndrome helps families and care teams plan supportive care sooner. Many strategies focus on protecting eyes and skin, supporting growth, and staying ahead of infections and joint problems.
Carrier testing and reproductive counseling can clarify the chance of De Barsy syndrome in a future pregnancy. Options may include prenatal testing or IVF with embryo testing, depending on local availability and personal values.
Staying up to date on vaccines lowers the risk of serious infections for children with De Barsy syndrome. Families can also ask about flu and RSV prevention during high‑risk seasons.
Good handwashing and avoiding close contact with people who are acutely ill can cut infection risk. This is especially important if feeding or breathing issues make infections harder to handle.
Regular eye checks and early treatment of vision problems help protect sight in De Barsy syndrome. Sunglasses and hats can reduce light sensitivity and protect the cornea.
Transmission
De Barsy syndrome is a genetic condition and is not infectious—you can’t catch it or spread it through coughing, touch, or everyday contact. Most often, a child has De Barsy syndrome after inheriting two nonworking copies of the same gene, one from each parent; this pattern is known medically as autosomal recessive.
When both parents are healthy carriers of the same gene change, each pregnancy has a 25% (1 in 4) chance of a child with De Barsy syndrome. Rarely, De Barsy syndrome can result from a new genetic change with no prior family history. A genetics professional can explain how De Barsy syndrome is inherited and discuss family testing; this kind of visit often covers the genetic transmission of De Barsy syndrome in clear, practical terms.
When to test your genes
De Barsy syndrome is a rare genetic condition; genetic testing is most useful when a clinician suspects it based on features like lax skin, developmental differences, or eye findings, to confirm the diagnosis and guide care. Test earlier in life if symptoms emerge in infancy. Parents may consider carrier testing for future family planning.
Diagnosis
People often first notice very loose skin, feeding challenges, or eye concerns in a baby, which leads to a closer look by specialists. With De Barsy syndrome, doctors usually combine what they see during an exam with targeted genetic tests to confirm what’s going on. Getting a diagnosis is often a turning point toward answers and support. Because features can overlap with other conditions that cause lax skin, a careful, stepwise approach helps ensure an accurate result.
Clinicians look for very loose, stretchy skin, a smaller build, joint laxity, and distinctive facial features. Developmental delays and low muscle tone may be present and guide testing.
An ophthalmologist checks for corneal clouding, cataracts, or lens position issues that are common in De Barsy syndrome. These findings can strongly support the suspected diagnosis.
Family history is often a key part of the diagnostic conversation. A detailed review of pregnancy, early growth, and any similar features in relatives can point toward an inherited cause.
A multigene panel or exome testing looks for pathogenic changes in genes linked to cutis laxa syndromes, most often PYCR1 or ALDH18A1. Identifying disease‑causing variants in both copies of a relevant gene confirms the genetic diagnosis of De Barsy syndrome.
Stages of De barsy syndrome
De barsy syndrome does not have defined progression stages. It’s a genetic condition present from birth, and features can shift over time in different ways rather than moving through set phases. Doctors usually start with a conversation about early symptoms of De barsy syndrome and a physical exam, then may add eye checks, imaging, and genetic testing to confirm the diagnosis. Ongoing care focuses on tracking growth, movement, vision, and hearing over time, with regular specialist visits to spot changes early.
Outlook and prognosis
Looking ahead can feel daunting, but most children with De Barsy syndrome do survive early childhood, and families often focus on maximizing comfort, growth, and communication. The condition can affect growth, muscle tone, joint movement, skin elasticity, vision, and hearing, so day-to-day needs vary widely. Everyone’s journey looks a little different. Some babies show early symptoms of De Barsy syndrome such as feeding challenges, low muscle tone, and developmental delays; others present more with eye problems or joint laxity first. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle, including access to therapies, nutrition support, and proactive eye and hearing care.
Over time, most people with De Barsy syndrome benefit from coordinated care that aims to prevent complications, support mobility, and protect vision. Severe complications—like breathing problems from infections, poor weight gain, or uncontrolled seizures—can raise health risks, and some children with more complex medical needs may have a shortened lifespan. That said, with attentive management, many living with De Barsy syndrome reach school age and beyond, and quality of life can be meaningful with adaptive equipment, therapies, and low-vision support. Prognosis refers to how a condition tends to change or stabilize over time.
Talk with your doctor about what your personal outlook might look like. A care team that includes pediatrics, neurology, ophthalmology, audiology, physical and occupational therapy, dietetics, and palliative or supportive care can tailor plans as needs change. Ask about early warning signs and what steps to take if they appear, such as feeding fatigue, breathing changes, or new seizure activity. Genetic testing can sometimes provide more insight into prognosis, but not everyone with the same gene change will have the same outlook.
Long-term effects
De Barsy syndrome has long-term effects that touch growth, movement, skin, vision, and hearing. These features usually begin in infancy and continue, with some changing as children grow into adolescence and adulthood. Long-term effects vary widely, and two people with the same diagnosis can have very different day-to-day needs.
Slow growth and lower-than-average weight often persist from infancy into later childhood. Many remain shorter and lighter than peers over time.
Global developmental delay and learning differences tend to be ongoing. Speech and communication usually progress, but at a slower pace.
Low muscle tone in infancy can shift toward stiffness and spasticity with age. This can affect posture, balance, and coordinated movements.
Delays in sitting, standing, and walking are common and may continue. Some children achieve assisted walking, while others rely on wheelchairs or strollers long-term.
How is it to live with De barsy syndrome?
Living with De Barsy syndrome often means navigating significant developmental delays, muscle stiffness, and joint looseness that can affect movement, feeding, and communication from early childhood. Daily life usually centers on coordinated care—regular physical, occupational, and speech therapies; vision and hearing support; and close medical follow-up for breathing, skin, and growth concerns—while adapting the home for safety and comfort. Many families build strong routines and rely on a team approach, which can be demanding for caregivers and siblings but also creates a shared rhythm and clear roles. Community resources, respite care, and connecting with other families can ease isolation and help everyone involved feel more supported and prepared.
Treatment and drugs
Treatment for De Barsy syndrome focuses on easing symptoms and supporting development, since there’s no single cure. Care teams often include pediatrics, neurology, ophthalmology, dermatology, physiotherapy, and nutrition to address muscle stiffness, feeding issues, vision problems, and skin laxity. Medicines that ease symptoms are called supportive or symptomatic treatments, and may include muscle relaxants for spasticity, anti‑seizure drugs if seizures occur, eye drops or surgery for corneal problems, and skin care to protect fragile skin. Alongside medical treatment, lifestyle choices play a role, with early physical, occupational, and speech therapy helping mobility, comfort, and communication, plus tailored nutrition plans to support growth. Not every treatment works the same way for every person, so regular follow‑up helps adjust therapies as needs change over time.
Non-drug treatment
De barsy syndrome affects skin, joints, development, and the senses, so care focuses on practical supports that help daily life. Non-drug treatments often lay the foundation for comfort, safety, and learning, starting in infancy and continuing as needs change. Plans are tailored, since features and severity can vary widely. Teams usually include rehabilitation therapists, dietitians, eye and hearing specialists, and genetic counselors.
Gentle, regular exercises can build strength, improve posture, and help with low muscle tone. Stretching and positioning may reduce joint laxity and prevent contractures.
Daily-skill training helps with dressing, play, and fine motor tasks. Adaptive tools and seating can make home and school activities safer and easier for children with De barsy syndrome.
Therapists assess swallowing and teach safer feeding techniques. Early work on communication may include speech, signs, or devices if speech is delayed.
Regular eye exams address corneal clouding, lens issues, and focus problems. Glasses, patching, or low-vision services can protect vision and support learning.
Your genes may have an impact on how drugs work for you
Even with rare conditions like De Barsy syndrome, how a person processes medications can hinge on inherited differences in liver enzymes—the body’s chemical “work crew” that breaks drugs down. These variations can change dose needs, effectiveness, and side‑effect risk, so clinicians individualize treatment.
Pharmacological treatments
There’s no single medicine that treats every feature of De Barsy syndrome, so doctors tailor drugs to the symptoms that affect daily life most—like seizures, reflux, breathing problems, eye irritation, or infections. Drugs that target symptoms directly are called symptomatic treatments. Medicines may change over time as needs shift, including when early symptoms of De Barsy syndrome evolve during infancy and childhood. Your care team will balance benefits with side effects and coordinate treatments across specialties.
Levetiracetam, valproate, or topiramate are commonly used to reduce seizure frequency. Not everyone responds to the same medication in the same way. Doctors may adjust the plan based on EEG findings and side effects.
Baclofen, trihexyphenidyl, or clonazepam can ease stiffness and involuntary movements. Dosing may be increased or lowered gradually to find the lowest effective amount. For focal problems, botulinum toxin injections may help specific muscles.
Omeprazole or lansoprazole (proton pump inhibitors) reduce stomach acid, while famotidine (an H2 blocker) is another option. These can lessen spit‑ups, discomfort, and feeding irritation. Positioning and feeding changes are usually paired with medicine.
Preservative‑free artificial tears such as carboxymethylcellulose or hyaluronate drops keep the cornea moist and more comfortable. Nighttime ointments can protect the eye during sleep. Antibiotic drops may be added short‑term if irritation leads to infection.
Genetic influences
In most families, De Barsy syndrome arises when a child inherits a changed copy of the same gene from both parents. Family history is one of the strongest clues to a genetic influence. Parents usually feel well and are carriers of a single gene change without symptoms; when both carry it, each pregnancy has a 1 in 4 (25%) chance of an affected child. The genes involved help the body build and maintain connective tissues, so changes in them most strongly affect the skin, eyes, joints, and growth. Different gene changes, and even differences between siblings with the same change, can lead to a range of severity. Genetic testing can identify the specific change, confirm De Barsy syndrome, and support counseling about future pregnancies and early care planning, sometimes even before early symptoms of De Barsy syndrome are obvious.
Is De barsy syndrome genetic?
Genetics are central in De Barsy syndrome. Most cases result from inherited changes in genes that affect elastic tissue and development, typically passed in an autosomal recessive pattern. Genetic testing confirms the diagnosis and guides family planning and recurrence risk.
Pharmacogenetics—how genetics influence drug effects
Treatment is mostly supportive, so genetics tends to guide which medicines are safest and how they’re dosed rather than offering a cure. In De barsy syndrome, different gene changes can lead to varying levels of muscle stiffness, seizures, eye problems, and feeding challenges, so doctors tailor medications to the individual’s needs. For seizures, for example, some anti-seizure drugs have known drug–gene interactions; certain genetic markers are linked to a higher risk of severe skin reactions with carbamazepine or phenytoin, and other markers can affect how quickly clobazam or diazepam are cleared, which may alter dosing. Similar gene effects can influence sedatives, pain relievers, and medicines for reflux or muscle stiffness, meaning some people need lower starting doses, closer monitoring, or different choices. Genetics is only one factor, though; other health conditions, age, nutrition, and drug interactions also play a major role in response. When available, pharmacogenetic testing is combined with clinical judgment to choose safer starting doses, watch for side effects early, and avoid medicines that carry higher risk for someone living with De barsy syndrome.
Interactions with other conditions
People living with De Barsy syndrome often find that common illnesses can have outsized effects because their connective tissues, lungs, eyes, and joints are more fragile. During a cold or flu, floppy airways and existing lung changes can make breathing harder, and recovery may take longer. A condition may “exacerbate” (make worse) symptoms of another, so reflux or swallowing trouble can increase the chance of chest infections from aspiration. Eye surface problems and corneal clouding mean even minor scratches or infections need quick treatment to avoid pain and vision loss. Fevers from infections can also lower the seizure threshold, so seizures may be more likely in those who have them. Early symptoms of De Barsy syndrome can be hard to separate from effects of other conditions, which is why coordinated care among pediatrics, genetics, lung and breathing specialists, neurology, and eye care is helpful.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described babies with loose, sagging skin who didn’t gain weight as expected and had trouble with vision. Families remembered relatives who seemed unusually small, sensitive to light, and slower to reach milestones. Doctors noted the same mix of features but used many different names, which made it hard to connect the dots.
From early case reports in the mid-20th century, patterns emerged: very lax skin, early-onset eye problems, stiff or jerky movements, and developmental delays. First described in the medical literature as a form of “progeroid” (premature-aging) condition, it was later recognized as a distinct picture. In 1967, Belgian pediatrician De Barsy and colleagues drew attention to that consistent cluster of findings, and over the next decades, De barsy syndrome appeared in medical journals as more children were reported with similar features.
Over time, descriptions became more precise. Clinicians noticed that some children had more severe vision loss, while others mainly showed strikingly loose skin and feeding difficulties. The name “De Barsy syndrome” settled in, but it shared space with older terms, which sometimes led to confusion with related connective tissue and premature-aging conditions. Not every early description was complete, yet together they built the foundation of today’s knowledge.
Advances in genetics in the 2000s and 2010s helped clarify the biology. Researchers linked many cases of De barsy syndrome to changes in genes that help cells handle proteins and elastic tissue. This explained why the skin can be lax, the eyes sensitive, and the nervous system affected. It also showed overlap with a broader group of conditions that share related gene changes, which is why doctors now talk about a spectrum rather than a single, rigid category.
With genetic testing becoming more available, more families finally received a clear name for what they had noticed for years. This shifted care from chasing separate symptoms to a coordinated plan that includes skin care, eye protection, physical therapy, nutrition support, and developmental services. For many, this can mean earlier interventions and better day-to-day comfort.
In recent decades, knowledge has built on a long tradition of observation. Registries and international collaborations have gathered detailed histories, photos, and genetic results to refine what we know about De barsy syndrome at different ages. Today, when a newborn shows very loose skin, feeding challenges, and early eye signs, clinicians consider De barsy syndrome sooner and confirm it with targeted genetic tests. The history of this condition—moving from scattered reports to a well-defined diagnosis—has opened the door to more timely support, informed family counseling, and ongoing research into tailored therapies.